Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas-ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2023

  1. Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study

    Free Radical Biology and Medicine, Vol. 194, pp. 52-61

2022

  1. Gene-environment interaction analysis of redox-related metals and genetic variants with plasma metabolic patterns in a general population from Spain: The Hortega Study

    Redox Biology, Vol. 52

  2. Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain

    International Journal of Behavioral Nutrition and Physical Activity, Vol. 19, Núm. 1

2021

  1. Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: The LipoLab Study

    International Journal of Clinical Practice, Vol. 75, Núm. 1

  2. Role of antiangiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 131-139

2020

  1. Srebf2 locus overexpression reduces body weight, total cholesterol and glucose levels in mice fed with two different diets

    Nutrients, Vol. 12, Núm. 10, pp. 1-15

2018

  1. LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study

    International Journal of Cardiology, Vol. 264, pp. 172-178

2017

  1. mRNA expression profiles obtained from microdissected pancreatic cancer cells can predict patient survival

    Oncotarget, Vol. 8, Núm. 62, pp. 104796-104805

2016

  1. Genomic and metabolomic profile associated to clustering of cardio-metabolic risk factors

    PLoS ONE, Vol. 11, Núm. 9

2014

  1. Genomic and metabolomic profile associated to microalbuminuria

    PLoS ONE, Vol. 9, Núm. 6

2012

  1. Metabolomic profiling in blood from umbilical cords of low birth weight newborns

    Journal of Translational Medicine, Vol. 10, Núm. 1

2011

  1. Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: Importance of genetic testing in the entire family

    Atherosclerosis, Vol. 218, Núm. 2, pp. 423-430